ストックスクリーナーアプリを入手
12.00
9.74%
-1.295
アフターアワーズ：
12.06
0.06
+0.50%
前日終値:
$13.29
開ける：
$13.43
24時間の取引高:
182.61K
Relative Volume:
2.10
時価総額：
$73.84M
収益：
$7.97M
当期純損益:
$-75.74M
株価収益率:
-0.4941
EPS:
-24.2853
ネットキャッシュフロー:
$-85.33M
1週間 パフォーマンス:
+11.32%
1か月 パフォーマンス:
+80.18%
6か月 パフォーマンス:
+55.64%
1年 パフォーマンス:
-64.78%
1日の値動き範囲:
$11.45
$13.69
1週間の範囲:
$10.49
$13.69
52週間の値動き範囲:
$3.76
$46.80
Aligos Therapeutics Inc Stock (ALGS) Company Profile
名前
Aligos Therapeutics Inc
セクター
電話
(800) 466-6059
住所
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO
ALGS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ALGS
Aligos Therapeutics Inc
|
12.00 | 81.81M | 7.97M | -75.74M | -85.33M | -24.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Aligos Therapeutics Inc Stock (ALGS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-18 | 再開されました | H.C. Wainwright | Buy |
| 2024-08-19 | 開始されました | H.C. Wainwright | Buy |
| 2023-01-06 | アップグレード | Jefferies | Hold → Buy |
| 2023-01-06 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-03-23 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-01-07 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-01-06 | ダウングレード | Jefferies | Buy → Hold |
| 2021-09-09 | 開始されました | SVB Leerink | Outperform |
| 2021-05-17 | 再開されました | Piper Sandler | Overweight |
| 2020-11-10 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-11-10 | 開始されました | JP Morgan | Overweight |
| 2020-11-10 | 開始されました | Jefferies | Buy |
| 2020-11-10 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Aligos Therapeutics Inc (ALGS) 最新ニュース
(ALGS) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
What analysts say about Aligos Therapeutics Inc stockPrice-to-Earnings Ratio Insights & Minimal Investment Portfolio - earlytimes.in
Aligos Therapeutics, Inc. (ALGS) Fundamental Analysis - Meyka
Aligos Therapeutics (ALGS) Issues Stock Options to New Employees - GuruFocus
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Globe and Mail
Aligos reports synergistic weight loss effect with THR-β agonist By Investing.com - Investing.com South Africa
Aligos Therapeutics (ALGS) Unveils Promising Data at HEP-DART 20 - GuruFocus
Aligos Therapeutics Highlights Positive Data on Pevifoscorvir Sodium and ALG-055009 at HEP-DART 2025 Meeting - Quiver Quantitative
Aligos Therapeutics (Nasdaq: ALGS) reports HBV and obesity data with up to 40% weight loss - Stock Titan
Aligos Therapeutics (NASDAQ:ALGS) Will Have To Spend Its Cash Wisely - Sahm
Contrasting Neurogene (NASDAQ:NGNE) & Aligos Therapeutics (NASDAQ:ALGS) - Defense World
Would You Still Hold Aligos Therapeutics Stock If It Fell 30%? - Trefis
Reviewing Aligos Therapeutics (NASDAQ:ALGS) and ANI Pharmaceuticals (NASDAQ:ANIP) - Defense World
Why Aligos Therapeutics Inc. (5WK0) stock could be next leaderWeekly Trend Summary & Safe Capital Growth Plans - Newser
How supply shortages influence Aligos Therapeutics Inc. (5WK0) stockJuly 2025 Gainers & Low Drawdown Investment Strategies - Newser
What dividend safety rating applies to Aligos Therapeutics Inc. (5WK0) stockGold Moves & AI Driven Stock Movement Reports - Newser
Can Aligos Therapeutics Inc. (5WK0) stock sustain margin levelsJuly 2025 Highlights & Verified Entry Point Signals - Newser
What is the fair value estimate for Aligos Therapeutics Inc. (5WK0) stock in 2025Gap Down & Long-Term Capital Growth Strategies - Newser
Is Aligos Therapeutics Inc. (5WK0) stock resilient in recession scenariosJuly 2025 Drop Watch & Comprehensive Market Scan Insights - Newser
Why Aligos Therapeutics Inc. stock is a value investor pickJuly 2025 Closing Moves & Consistent Income Trade Ideas - Newser
Can Aligos Therapeutics Inc. stock beat market expectations this quarter2025 EndofYear Setup & Accurate Entry and Exit Point Alerts - Newser
Will Aligos Therapeutics Inc. (5WK0) stock split increase liquidityMarket Movers & Free Real-Time Volume Trigger Notifications - Newser
Responsive Playbooks and the ALGS Inflection - news.stocktradersdaily.com
Sio Capital Management LLC Increases Stock Position in Aligos Therapeutics, Inc. $ALGS - MarketBeat
Why analysts upgrade Aligos Therapeutics Inc. stockPortfolio Gains Report & Fast Momentum Entry Tips - BỘ NỘI VỤ
Aligos Therapeutics Stock Rockets 57% With 7-Day Winning Streak - Trefis
Understanding the Setup: (ALGS) and Scalable Risk - news.stocktradersdaily.com
Is Aligos Therapeutics Inc. (5WK0) stock a good hedge against inflationJuly 2025 Sector Moves & Breakout Confirmation Alerts - newser.com
Why Aligos Therapeutics Inc. stock could outperform in 2025Market Growth Summary & AI Optimized Trade Strategies - newser.com
Transcript : Aligos Therapeutics, Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-17-2025 03 - MarketScreener
Is Aligos Therapeutics Inc. stock undervalued vs historical averagesEntry Point & Entry Point Confirmation Alerts - newser.com
What moving averages say about Aligos Therapeutics Inc.2025 Key Highlights & Risk Controlled Stock Alerts - newser.com
Will Aligos Therapeutics Inc. (5WK0) stock outperform global peersJuly 2025 Analyst Calls & Short-Term High Return Ideas - newser.com
When is the best time to exit Aligos Therapeutics Inc.July 2025 Earnings & High Win Rate Trade Alerts - newser.com
Is Aligos Therapeutics Inc. (5WK0) stock a buy on weaknessOptions Play & Community Driven Trade Alerts - newser.com
What makes Aligos Therapeutics Inc. (5WK0) stock appealing to growth investorsMarket Performance Recap & Technical Confirmation Trade Alerts - newser.com
How buybacks impact Aligos Therapeutics Inc. stock valueBull Run & Accurate Trade Setup Notifications - newser.com
Will Aligos Therapeutics Inc. benefit from macro trendsJuly 2025 Closing Moves & Verified Momentum Stock Ideas - newser.com
Aligos Therapeutics Inc (ALGS) 財務データ
収益
当期純利益
現金流量
EPS
0.36%
1.05%
大文字化:
|
ボリューム (24 時間):